BlackRock’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28M | Buy |
5,463,266
+1,431,254
| +35% | +$7.33M | ﹤0.01% | 2779 |
|
|
2025
Q1 | $5.52M | Sell |
4,032,012
-346,491
| -8% | -$475K | ﹤0.01% | 3564 |
|
|
2024
Q4 | $13.5M | Buy |
4,378,503
+17,168
| +0.4% | +$53K | ﹤0.01% | 3221 |
|
|
2024
Q3 | $33.6M | Buy |
4,361,335
+373,483
| +9% | +$2.88M | ﹤0.01% | 2669 |
|
|
2024
Q2 | $34.2M | Buy |
3,987,852
+126,490
| +3% | +$1.09M | ﹤0.01% | 2617 |
|
|
2024
Q1 | $30.7M | Sell |
3,861,362
-87,914
| -2% | -$698K | ﹤0.01% | 2688 |
|
|
2023
Q4 | $39.1M | Buy |
3,949,276
+391,757
| +11% | +$3.88M | ﹤0.01% | 2586 |
|
|
2023
Q3 | $40.1M | Sell |
3,557,519
-64,957
| -2% | -$731K | ﹤0.01% | 2493 |
|
|
2023
Q2 | $12M | Buy |
3,622,476
+83,564
| +2% | +$277K | ﹤0.01% | 3262 |
|
|
2023
Q1 | $14M | Sell |
3,538,912
-12,259
| -0.3% | -$48.4K | ﹤0.01% | 3083 |
|
|
2022
Q4 | $25.7M | Buy |
3,551,171
+630,761
| +22% | +$4.57M | ﹤0.01% | 2845 |
|
|
2022
Q3 | $10.6M | Sell |
2,920,410
-239,977
| -8% | -$869K | ﹤0.01% | 3336 |
|
|
2022
Q2 | $14.3M | Buy |
3,160,387
+1,667,201
| +112% | +$7.55M | ﹤0.01% | 3223 |
|
|
2022
Q1 | $11.3M | Buy |
1,493,186
+340,746
| +30% | +$2.58M | ﹤0.01% | 3433 |
|
|
2021
Q4 | $12.6M | Sell |
1,152,440
-240,728
| -17% | -$2.63M | ﹤0.01% | 3468 |
|
|
2021
Q3 | $18M | Buy |
1,393,168
+793,168
| +132% | +$10.3M | ﹤0.01% | 3307 |
|
|
2021
Q2 | $6.83M | Hold |
600,000
| – | – | ﹤0.01% | 3722 |
|
|
2021
Q1 | $6.67M | Hold |
600,000
| – | – | ﹤0.01% | 3745 |
|
|
2020
Q4 | $6.86M | Hold |
600,000
| – | – | ﹤0.01% | 3490 |
|
|
2020
Q3 | $6.22M | Buy |
+600,000
| New | +$6.22M | ﹤0.01% | 3387 |
|